Header Logo

Susan Andrade

Concepts (390)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Databases, Factual
25
2021
707
3.170
Why?
Drug Prescriptions
16
2019
172
2.400
Why?
Health Maintenance Organizations
28
2013
100
2.130
Why?
Pregnancy
30
2021
1842
2.030
Why?
Drug Utilization
12
2018
215
1.690
Why?
International Classification of Diseases
9
2021
122
1.660
Why?
Pregnancy Complications
6
2018
380
1.360
Why?
Serotonin Uptake Inhibitors
4
2016
112
1.340
Why?
Algorithms
13
2021
829
1.310
Why?
Patient Compliance
10
2018
341
1.260
Why?
Drug Therapy
8
2019
53
1.160
Why?
Hypoglycemic Agents
6
2019
190
1.150
Why?
Diabetes Mellitus
6
2019
487
1.050
Why?
United States
44
2019
5955
1.020
Why?
Hypolipidemic Agents
7
2008
36
1.010
Why?
Retrospective Studies
38
2021
4121
0.990
Why?
Pregnancy Outcome
6
2015
163
0.970
Why?
Diabetes, Gestational
3
2019
116
0.950
Why?
Depressive Disorder
3
2016
278
0.950
Why?
Stillbirth
1
2021
13
0.940
Why?
Female
83
2021
25625
0.940
Why?
Antidepressive Agents
5
2015
205
0.900
Why?
Prenatal Exposure Delayed Effects
5
2019
148
0.890
Why?
Humans
102
2021
46418
0.870
Why?
Prenatal Care
5
2016
177
0.860
Why?
Pregnancy in Diabetics
1
2019
8
0.860
Why?
Middle Aged
61
2019
13345
0.850
Why?
Antipsychotic Agents
2
2013
291
0.810
Why?
Cardiovascular System
1
2019
26
0.800
Why?
Death, Sudden, Cardiac
2
2019
55
0.800
Why?
Estrogen Replacement Therapy
6
2008
96
0.790
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2016
169
0.780
Why?
Adult
46
2019
12984
0.780
Why?
Abnormalities, Drug-Induced
4
2015
21
0.770
Why?
Insurance, Health
2
2012
107
0.750
Why?
Prescription Drugs
2
2016
46
0.740
Why?
Dipyrone
2
2016
3
0.730
Why?
Adolescent
26
2019
5384
0.720
Why?
Birth Certificates
4
2013
10
0.710
Why?
Infant, Newborn
14
2016
1007
0.690
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
2014
183
0.690
Why?
Pharmacoepidemiology
4
2013
12
0.670
Why?
Young Adult
17
2019
3559
0.650
Why?
Cohort Studies
25
2018
2032
0.640
Why?
Drug Utilization Review
4
2018
57
0.630
Why?
Prevalence
12
2016
1089
0.630
Why?
Practice Patterns, Physicians'
8
2017
670
0.620
Why?
Validation Studies as Topic
2
2012
24
0.610
Why?
Registries
5
2018
663
0.590
Why?
Diphosphonates
4
2010
31
0.590
Why?
Research Design
5
2019
523
0.580
Why?
Pharmaceutical Preparations
3
2012
105
0.560
Why?
Drug Labeling
6
2014
29
0.560
Why?
Predictive Value of Tests
12
2013
850
0.540
Why?
Prescriptions
1
2013
13
0.530
Why?
Medical Records Systems, Computerized
5
2013
69
0.530
Why?
Medication Adherence
6
2010
223
0.530
Why?
Aged
45
2015
10613
0.500
Why?
Osteoporosis, Postmenopausal
3
2010
76
0.480
Why?
Adverse Drug Reaction Reporting Systems
5
2018
43
0.460
Why?
Ischemic Attack, Transient
1
2012
74
0.460
Why?
Population Surveillance
6
2014
220
0.450
Why?
Estrogens
4
2008
115
0.440
Why?
Gestational Age
2
2013
148
0.440
Why?
Teratogens
2
2008
9
0.430
Why?
Schizophrenia
1
2013
255
0.430
Why?
Cardiovascular Agents
2
2008
82
0.430
Why?
Live Birth
3
2019
19
0.430
Why?
Fractures, Bone
4
2010
138
0.410
Why?
Persistent Fetal Circulation Syndrome
1
2009
4
0.410
Why?
Biomedical Research
1
2012
226
0.400
Why?
Pregnancy Trimesters
3
2018
13
0.400
Why?
Gout
5
2010
47
0.380
Why?
Pregnancy Complications, Cardiovascular
1
2008
16
0.380
Why?
Data Collection
3
2019
383
0.370
Why?
Rheumatic Diseases
1
2008
29
0.360
Why?
Insurance, Pharmaceutical Services
4
2010
22
0.360
Why?
Hyperlipidemias
2
1999
51
0.360
Why?
Pregnancy Trimester, First
2
2019
31
0.360
Why?
Male
44
2015
22866
0.360
Why?
Drug Monitoring
6
2007
97
0.350
Why?
Bone Density Conservation Agents
4
2010
48
0.340
Why?
Infant
6
2021
1323
0.340
Why?
Antihypertensive Agents
1
2008
140
0.340
Why?
United States Food and Drug Administration
5
2016
80
0.330
Why?
Osteoporosis
5
2010
132
0.320
Why?
Antirheumatic Agents
1
2008
164
0.320
Why?
Stroke
3
2012
786
0.310
Why?
Child
9
2019
3626
0.310
Why?
Medical Records
4
2014
143
0.310
Why?
Hospital Information Systems
1
2005
14
0.300
Why?
Muscular Diseases
1
2005
39
0.300
Why?
Ambulatory Care
6
2007
258
0.290
Why?
Drug-Related Side Effects and Adverse Reactions
4
2012
125
0.290
Why?
Medical Record Linkage
3
2013
22
0.280
Why?
Insurance Claim Review
5
2012
65
0.280
Why?
Consumer Product Safety
2
2014
14
0.280
Why?
Gastrointestinal Hemorrhage
2
2002
96
0.280
Why?
Aged, 80 and over
20
2015
4136
0.280
Why?
Calcitonin
1
2003
21
0.280
Why?
Endpoint Determination
2
2014
26
0.270
Why?
Hip Fractures
2
2003
67
0.270
Why?
Drug Approval
2
2014
27
0.270
Why?
Government Regulation
2
2014
44
0.270
Why?
Therapeutics
1
2002
8
0.260
Why?
Rhabdomyolysis
4
2007
22
0.260
Why?
Chemical and Drug Induced Liver Injury
1
2003
40
0.260
Why?
Observational Studies as Topic
2
2019
29
0.250
Why?
Risk Management
1
2002
50
0.250
Why?
Dementia
2
2014
167
0.250
Why?
Peptic Ulcer
1
2002
20
0.250
Why?
Fees, Pharmaceutical
1
2002
6
0.250
Why?
Risk Assessment
7
2015
1564
0.250
Why?
Churg-Strauss Syndrome
3
2007
12
0.240
Why?
Hypertension
3
2008
498
0.240
Why?
Lymphoma, Non-Hodgkin
1
2021
41
0.230
Why?
Product Surveillance, Postmarketing
3
2013
18
0.230
Why?
Formularies as Topic
1
2000
1
0.230
Why?
Gout Suppressants
3
2010
25
0.230
Why?
Estrogens, Conjugated (USP)
1
2000
30
0.220
Why?
Practice Guidelines as Topic
1
2004
602
0.220
Why?
Glyburide
1
2019
6
0.210
Why?
Administrative Claims, Healthcare
1
2019
12
0.210
Why?
Delivery, Obstetric
2
2013
42
0.210
Why?
Quality of Health Care
1
2004
483
0.210
Why?
Histamine H2 Antagonists
1
1999
9
0.200
Why?
Nonprescription Drugs
1
1999
18
0.200
Why?
Aromatase Inhibitors
1
2019
10
0.200
Why?
Maternal Age
2
2016
33
0.200
Why?
Mortality
2
2004
149
0.200
Why?
Pregnancy Complications, Neoplastic
1
2018
12
0.200
Why?
Women's Health
3
2014
391
0.200
Why?
Diabetes Mellitus, Type 2
4
2011
569
0.190
Why?
Fertilization
1
2019
82
0.190
Why?
Manufacturing Industry
1
2018
3
0.190
Why?
Cardiovascular Diseases
4
2011
698
0.180
Why?
Angiotensin II Type 1 Receptor Blockers
2
2008
25
0.180
Why?
Sensitivity and Specificity
5
2013
910
0.180
Why?
Morning Sickness
1
2017
3
0.180
Why?
Incidence
6
2018
1092
0.180
Why?
Ondansetron
1
2017
12
0.180
Why?
Patient Safety
1
2019
181
0.170
Why?
Antiemetics
1
2017
23
0.170
Why?
Sulfonamides
2
2015
102
0.170
Why?
Creatinine
2
2007
106
0.170
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2008
119
0.170
Why?
Progestins
2
2008
27
0.170
Why?
Outpatients
2
2008
94
0.170
Why?
Potassium
2
2007
92
0.170
Why?
Sentinel Surveillance
1
2016
14
0.170
Why?
Epidemiologic Studies
1
2016
41
0.170
Why?
Delivery of Health Care
2
2015
271
0.160
Why?
Europe
1
2016
149
0.160
Why?
Trimethoprim
1
2015
6
0.160
Why?
Pregnancy Trimester, Third
3
2013
26
0.160
Why?
Data Mining
2
2013
41
0.160
Why?
Anti-Asthmatic Agents
2
2007
36
0.160
Why?
Age Factors
10
2010
1431
0.160
Why?
Safety
1
2016
131
0.160
Why?
Hospitalization
5
2004
1013
0.160
Why?
Insulin
1
2019
666
0.150
Why?
Medical Futility
1
2014
5
0.150
Why?
Health Services Misuse
1
2014
19
0.150
Why?
Drug Substitution
1
2014
33
0.150
Why?
Evaluation Studies as Topic
3
2005
112
0.150
Why?
Monitoring, Physiologic
2
2006
126
0.150
Why?
Labor, Induced
1
2014
24
0.150
Why?
Risk Factors
9
2015
4147
0.150
Why?
Medication Errors
2
2005
105
0.140
Why?
Epilepsy
2
2012
68
0.140
Why?
Bone Density
3
2010
156
0.140
Why?
Risk
5
2012
386
0.140
Why?
Inappropriate Prescribing
1
2014
47
0.140
Why?
Insurance Coverage
1
2014
85
0.140
Why?
Drug Administration Schedule
5
2010
246
0.140
Why?
Infectious Disease Transmission, Vertical
1
2014
64
0.140
Why?
Pregnancy Complications, Infectious
1
2014
62
0.130
Why?
Health Care Surveys
2
2013
272
0.130
Why?
Socioeconomic Factors
2
2013
782
0.130
Why?
Homes for the Aged
1
2014
140
0.130
Why?
Perinatal Care
1
2013
41
0.130
Why?
Asthma
2
2007
348
0.130
Why?
Antifungal Agents
1
2013
99
0.130
Why?
Child, Preschool
4
2011
1747
0.120
Why?
Nursing Homes
2
2014
491
0.120
Why?
Anticonvulsants
1
2012
63
0.120
Why?
Hyperglycemia
1
2013
103
0.120
Why?
Epidemiology
1
2011
8
0.120
Why?
Cognition
1
2015
326
0.120
Why?
Central Nervous System Stimulants
1
2011
66
0.120
Why?
Gynecology
1
2011
51
0.120
Why?
Specialization
1
2011
67
0.110
Why?
Massachusetts
6
2010
2024
0.110
Why?
Reproducibility of Results
2
2015
1288
0.110
Why?
Antiviral Agents
1
2014
229
0.110
Why?
Random Allocation
1
2011
198
0.110
Why?
Osteoarthritis
2
2002
43
0.110
Why?
Treatment Outcome
7
2010
3703
0.110
Why?
Cooperative Behavior
1
2012
199
0.110
Why?
Calcium Channel Blockers
1
2010
56
0.110
Why?
Obstetrics
1
2011
71
0.110
Why?
Alzheimer Disease
1
2014
327
0.110
Why?
Women
1
2010
43
0.110
Why?
Hypoglycemia
1
2010
50
0.110
Why?
Hyperkalemia
2
2007
16
0.110
Why?
Drug Costs
2
2002
53
0.110
Why?
Patient Preference
1
2010
61
0.110
Why?
Seizures
1
2010
69
0.110
Why?
Confidence Intervals
5
2009
257
0.110
Why?
Bone Resorption
1
2010
44
0.110
Why?
Sex Factors
6
2010
852
0.110
Why?
Neoplasms
1
2018
886
0.110
Why?
Adrenergic beta-Antagonists
1
2010
125
0.110
Why?
Attention Deficit Disorder with Hyperactivity
1
2011
169
0.110
Why?
Cross-Sectional Studies
6
2015
1957
0.100
Why?
Drugs, Generic
1
2009
14
0.100
Why?
Insurance, Health, Reimbursement
1
2009
22
0.100
Why?
Models, Statistical
1
2011
302
0.100
Why?
Metformin
2
2013
47
0.100
Why?
Pharmacies
2
2006
26
0.100
Why?
Polypharmacy
2
2006
50
0.100
Why?
Maternal-Fetal Exchange
1
2009
33
0.100
Why?
Insulin Resistance
1
2013
389
0.100
Why?
Anti-Bacterial Agents
3
2015
546
0.100
Why?
Interviews as Topic
1
2010
427
0.100
Why?
Epidemiologic Methods
3
2010
72
0.100
Why?
Decision Support Techniques
1
2010
155
0.100
Why?
Progesterone Congeners
2
2005
9
0.100
Why?
Chronic Disease
4
2010
667
0.100
Why?
Guideline Adherence
3
2006
270
0.090
Why?
Health Services Research
2
2013
252
0.090
Why?
Irritable Bowel Syndrome
1
2008
8
0.090
Why?
Comorbidity
5
2014
977
0.090
Why?
Gemfibrozil
1
2007
1
0.090
Why?
Fenofibrate
1
2007
2
0.090
Why?
Spironolactone
1
2007
5
0.090
Why?
Fetus
1
2007
87
0.090
Why?
Amiodarone
1
2006
11
0.090
Why?
Wrist Injuries
2
2003
11
0.080
Why?
Inflammatory Bowel Diseases
1
2007
58
0.080
Why?
Health Knowledge, Attitudes, Practice
2
2010
715
0.080
Why?
Odds Ratio
4
2014
771
0.080
Why?
Thyroid Gland
1
2006
72
0.080
Why?
Spinal Fractures
2
2003
42
0.080
Why?
Correspondence as Topic
1
2005
7
0.080
Why?
Prescription Fees
1
2005
6
0.080
Why?
Pharmacovigilance
2
2018
7
0.080
Why?
Breast Neoplasms
3
2018
951
0.080
Why?
Time Factors
5
2014
3218
0.080
Why?
Cost Sharing
1
2005
10
0.080
Why?
Self Administration
1
2005
39
0.080
Why?
Heart Failure
1
2012
634
0.080
Why?
Drug Design
1
2006
134
0.080
Why?
Clofibric Acid
1
2004
1
0.080
Why?
Sulfonylurea Compounds
1
2004
15
0.070
Why?
Macrolides
1
2004
30
0.070
Why?
Enzyme Inhibitors
1
2006
317
0.070
Why?
Uric Acid
3
2010
44
0.070
Why?
Health Services
1
2005
86
0.070
Why?
Chi-Square Distribution
3
2013
405
0.070
Why?
Sex Distribution
3
2015
245
0.070
Why?
Age Distribution
3
2015
249
0.070
Why?
Data Interpretation, Statistical
1
2005
195
0.070
Why?
Patient Acceptance of Health Care
1
2008
405
0.070
Why?
Liver Function Tests
1
2003
38
0.070
Why?
Postmenopause
1
2005
288
0.070
Why?
Disease Management
1
2004
177
0.060
Why?
Obesity
1
2011
1150
0.060
Why?
Stomach Ulcer
1
2002
9
0.060
Why?
Duodenal Ulcer
1
2002
9
0.060
Why?
Intestinal Perforation
1
2002
11
0.060
Why?
Follow-Up Studies
3
2015
1936
0.060
Why?
Duodenal Diseases
1
2002
17
0.060
Why?
Alendronate
1
2002
17
0.060
Why?
Liver
1
2006
675
0.060
Why?
Coronary Disease
2
2004
358
0.060
Why?
Managed Care Programs
3
2008
88
0.060
Why?
Databases as Topic
3
2007
56
0.060
Why?
Electronics
1
2021
26
0.060
Why?
Cisapride
1
2000
1
0.060
Why?
Legislation, Drug
1
2000
14
0.060
Why?
Gastrointestinal Agents
1
2000
16
0.060
Why?
Phosphodiesterase Inhibitors
1
2000
20
0.060
Why?
Erectile Dysfunction
1
2000
16
0.060
Why?
Drug Therapy, Combination
3
2007
371
0.060
Why?
Esterification
1
2000
5
0.060
Why?
Esters
1
2000
15
0.060
Why?
Cost Control
1
2000
24
0.060
Why?
Piperazines
1
2000
97
0.050
Why?
Allopurinol
2
2010
17
0.050
Why?
Electronic Health Records
2
2013
260
0.050
Why?
Cholesterol, LDL
1
1999
111
0.050
Why?
Insemination, Artificial
1
2019
4
0.050
Why?
Diclofenac
1
1998
2
0.050
Why?
Drug Evaluation
1
1998
19
0.050
Why?
Office Visits
1
1999
36
0.050
Why?
Competitive Medical Plans
2
2009
4
0.050
Why?
Drug and Narcotic Control
1
1998
29
0.050
Why?
Genital Neoplasms, Female
1
2018
26
0.050
Why?
Acetaminophen
1
1998
45
0.050
Why?
Medicare
1
2002
403
0.050
Why?
Fertilization in Vitro
1
2019
83
0.050
Why?
Hematologic Neoplasms
1
2018
34
0.050
Why?
Case-Control Studies
3
2007
860
0.050
Why?
Thyroid Neoplasms
1
2018
64
0.050
Why?
Logistic Models
3
2009
1202
0.050
Why?
Aspirin
1
1998
169
0.040
Why?
Administration, Oral
2
2010
292
0.040
Why?
Postpartum Period
1
2018
131
0.040
Why?
Clinical Laboratory Techniques
2
2006
45
0.040
Why?
Melanoma
1
2018
265
0.040
Why?
Mental Status Schedule
1
2014
18
0.040
Why?
Obstetric Labor Complications
1
2014
13
0.040
Why?
Sulfones
2
2007
34
0.040
Why?
New England
2
2006
245
0.040
Why?
Proportional Hazards Models
2
2010
624
0.040
Why?
Hospice Care
1
2014
36
0.040
Why?
Terminal Care
1
2014
55
0.040
Why?
Multivariate Analysis
2
2009
876
0.040
Why?
Reference Values
1
2015
325
0.040
Why?
Pilot Projects
1
2017
704
0.040
Why?
Multicenter Studies as Topic
1
2014
74
0.030
Why?
Geriatric Assessment
1
2015
146
0.030
Why?
Contraindications
2
2005
36
0.030
Why?
Pregnancy, Multiple
1
2013
13
0.030
Why?
Likelihood Functions
1
2013
74
0.030
Why?
Myocardial Infarction
2
2011
860
0.030
Why?
Pregnancy Trimester, Second
1
2013
34
0.030
Why?
Polycystic Ovary Syndrome
1
2013
21
0.030
Why?
Infertility, Female
1
2013
46
0.030
Why?
Randomized Controlled Trials as Topic
1
1995
473
0.030
Why?
Severity of Illness Index
2
2010
1172
0.030
Why?
Disease Progression
1
2014
673
0.030
Why?
Continental Population Groups
1
2013
181
0.030
Why?
Quality Improvement
1
2014
306
0.030
Why?
Absorptiometry, Photon
1
2010
79
0.030
Why?
Ethnic Groups
1
2013
340
0.030
Why?
Colchicine
1
2010
29
0.030
Why?
Program Evaluation
1
2012
451
0.030
Why?
Primary Health Care
1
1995
530
0.030
Why?
Probability
1
2010
165
0.030
Why?
Sulfinpyrazone
1
2009
3
0.030
Why?
Probenecid
1
2009
6
0.030
Why?
Kaplan-Meier Estimate
1
2010
351
0.020
Why?
Drug Administration Routes
1
2008
6
0.020
Why?
Glucocorticoids
1
2010
128
0.020
Why?
Hypothyroidism
1
2008
26
0.020
Why?
Naproxen
1
2007
7
0.020
Why?
Celecoxib
1
2007
15
0.020
Why?
Lactones
1
2007
14
0.020
Why?
Antidepressive Agents, Tricyclic
1
2007
20
0.020
Why?
Dose-Response Relationship, Drug
1
2010
748
0.020
Why?
Obstetric Labor, Premature
1
2007
29
0.020
Why?
Hypercholesterolemia
1
2008
72
0.020
Why?
Leukotriene Antagonists
1
2007
8
0.020
Why?
Pyrazoles
1
2007
55
0.020
Why?
Observation
1
2007
25
0.020
Why?
Pyridines
1
2007
89
0.020
Why?
Health Surveys
1
2008
314
0.020
Why?
Surveys and Questionnaires
1
2015
2223
0.020
Why?
Insurance Claim Reporting
1
2006
19
0.020
Why?
Pharmacology, Clinical
1
2006
2
0.020
Why?
Diagnostic Errors
1
2007
86
0.020
Why?
Adrenal Cortex Hormones
1
2007
98
0.020
Why?
Diuretics
1
2006
52
0.020
Why?
Medical Audit
1
2006
55
0.020
Why?
Episode of Care
1
2005
8
0.020
Why?
Kidney Diseases
1
2007
122
0.020
Why?
Financing, Personal
1
2005
19
0.020
Why?
Drug Industry
1
2005
35
0.020
Why?
Patient Satisfaction
1
2008
367
0.020
Why?
Community Pharmacy Services
1
2004
11
0.020
Why?
Longitudinal Studies
1
2008
1021
0.020
Why?
Regression Analysis
1
2005
479
0.020
Why?
Treatment Refusal
1
2004
61
0.020
Why?
Blood Glucose
1
2006
445
0.020
Why?
Heart Diseases
1
2005
175
0.020
Why?
Epidemiologic Research Design
1
2002
8
0.020
Why?
Evidence-Based Medicine
1
2005
358
0.020
Why?
Health Resources
1
2002
72
0.020
Why?
Physicians
1
2005
345
0.010
Why?
Sildenafil Citrate
1
2000
6
0.010
Why?
Health Care Costs
1
2002
152
0.010
Why?
Purines
1
2000
30
0.010
Why?
Sex Ratio
1
2000
9
0.010
Why?
Humeral Fractures
1
2000
4
0.010
Why?
Tibial Fractures
1
2000
12
0.010
Why?
Protective Agents
1
2000
8
0.010
Why?
Osteogenesis
1
2000
110
0.010
Why?
Patient Admission
1
2000
160
0.010
Why?
Andrade's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (390)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_